S'abonner

Sex Differences in Symptom Phenotypes Among Older Patients with Acute Myocardial Infarction - 03/03/22

Doi : 10.1016/j.amjmed.2021.09.022 
John E. Brush, MD a, , Alexandra M. Hajduk, PhD, MPH b, Erich J. Greene, PhD c, Rachel P. Dreyer, PhD d, e, Harlan M. Krumholz, MD, SM c, d, e, Sarwat I. Chaudhry, MD f
a Sentara Healthcare and Eastern Virginia Medical School, Norfolk 
b Section of Geriatrics, Department of Internal Medicine, Yale School of Medicine, New Haven, Conn 
c Department of Health Policy and Management and Department of Biostatistics, Yale School of Medicine, New Haven, Conn 
d Section of Cardiovascular Medicine, Department of Internal Medicine and Department of Emergency Medicine, Yale School of Medicine, New Haven, Conn 
e Yale School of Public Health; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Conn 
f Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Conn 

Requests for reprints should be addressed to John E. Brush, Jr., MD, Sentara Healthcare and Eastern Virginia Medical School, 835 Glenrock Road, Suite 220, Norfolk, VA, 23502.Sentara Healthcare and Eastern Virginia Medical School835 Glenrock Road, Suite 220NorfolkVA,23502

Abstract

Background

Clinicians make a medical diagnosis by recognizing diagnostic possibilities, often using memories of prior examples. These memories, called “exemplars,” reflect specific symptom combinations in individual patients, yet most clinical studies report how symptoms aggregate in populations. We studied how symptoms of acute myocardial infarction combine in individuals as symptom phenotypes and how symptom phenotypes are distributed in women and men.

Methods

In this analysis of the SILVER-AMI Study, we studied 3041 patients (1346 women and 1645 men) 75 years of age or older with acute myocardial infarction. Each patient had a standardized in-person interview during the acute myocardial infarction admission to document the presenting symptoms, which enabled a thorough examination of symptom combinations in individuals. Specific symptom combinations defined symptom phenotypes and distributions of symptom phenotypes were compared in women and men using Monte Carlo permutation testing and repeated subsampling.

Results

There were 1469 unique symptom phenotypes in the entire SILVER-AMI cohort of patients with acute myocardial infarction. There were 831 unique symptom phenotypes in women, as compared with 819 in men, which was highly significant, given the larger number of men than women in the study (P < .0001). Women had significantly more symptom phenotypes than men in almost all acute myocardial infarction subgroups.

Conclusions

Older patients with acute myocardial infarction have enormous variation in symptom phenotypes. Women reported more symptoms and had significantly more symptom phenotypes than men. Appreciation of the diversity of symptom phenotypes may help clinicians recognize the less common phenotypes that occur more often in women.

Le texte complet de cet article est disponible en PDF.

Keywords : Acute myocardial infarction, Diagnostic reasoning, Gender disparities


Plan


 Funding: This research was supported by grant R01 HL115295 from the National Heart, Lung, and Blood Institute. This SILVER-AMI study was conducted at the Yale Claude D. Pepper Older Americans Independence Center (grant P30 AG021342).
 Conflicts of Interest: AMH, EJG, RPD report none. JEBJ receives royalties from Dementi Milestone Publishing for the book The Science of the Art of Medicine: A Guide to Medical Reasoning. HMK reports expenses and/or personal fees from UnitedHealth, IBM Watson Health, Element Science, Aetna, Facebook, the Siegfried and Jensen Law Firm, Arnold and Porter Law Firm, Martin/Baughman Law Firm, F-Prime, and the National Center for Cardiovascular Diseases in Beijing; being a cofounder of Refactor Health and HugoHealth; and grants and/or contracts from the Centers for Medicare & Medicaid Services, Medtronic, US Food and Drug Administration, Johnson & Johnson, Foundation for a Smoke-Free World, State of Connecticut Department of Public Health, and the Shenzhen Center for Health Information. SIC reports serving as a reviewer for the CVS Caremark State of Connecticut Clinical Program. The other authors report no disclosures.
 Authorship: All authors had access to the data and a role in writing this manuscript.


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 135 - N° 3

P. 342-349 - mars 2022 Retour au numéro
Article précédent Article précédent
  • Reducing ICU Utilization, Length of Stay, and Cost by Optimizing the Clinical Use of Continuous Monitoring System Technology in the Hospital
  • Patricia C. Dykes, Graham Lowenthal, Stuart Lipsitz, Suzanne M. Salvucci, Catherine Yoon, David W. Bates, Perry G. An
| Article suivant Article suivant
  • The Impact of an Inpatient Pancreatitis Service and Educational Intervention Program on the Outcome of Acute Pancreatitis
  • Cinthana Kandasamy, Ishani Shah, William Yakah, Awais Ahmed, Supisara Tintara, Cristina Sorrento, Steven D. Freedman, Darshan J. Kothari, Sunil G. Sheth

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.